230 related articles for article (PubMed ID: 28951777)
1. Hepatitis B in renal transplant patients.
Marinaki S; Kolovou K; Sakellariou S; Boletis JN; Delladetsima IK
World J Hepatol; 2017 Sep; 9(25):1054-1063. PubMed ID: 28951777
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of viral hepatitis in solid organ transplantation].
Mikolašević I; Sladoje-Martinović B; Orlić L; Milić S; Lukenda V; Župan Ž; Štimac D; Rački S
Acta Med Croatica; 2014 Apr; 68(2):151-9. PubMed ID: 26012153
[TBL] [Abstract][Full Text] [Related]
3. Lamivudine prophylaxis and treatment of hepatitis B Virus-exposed recipients receiving reduced intensity conditioning hematopoietic stem cell transplants with alemtuzumab.
Moses SE; Lim ZY; Sudhanva M; Devereux S; Ho AY; Pagliuca A; Zuckerman M; Mufti GJ
J Med Virol; 2006 Dec; 78(12):1560-3. PubMed ID: 17063522
[TBL] [Abstract][Full Text] [Related]
4. Anti-HBc impacts on the risk of hepatitis B reactivation but not on survival of solid-organ transplant recipients.
Álvarez-López P; Riveiro-Barciela M; Oleas-Vega D; Flores-Cortes C; Román A; Perelló M; Berastegui C; Castells L; Esteban R; Buti M
Medicine (Baltimore); 2020 Feb; 99(9):e19407. PubMed ID: 32118794
[TBL] [Abstract][Full Text] [Related]
5. Escape hepatitis B virus mutations in recipients of antibody to hepatitis B core antigen-positive liver grafts receiving hepatitis B immunoglobulins.
Roche B; Roque-Afonso AM; Sebagh M; Delvart V; Duclos-Vallee JC; Castaing D; Samuel D
Liver Transpl; 2010 Jul; 16(7):885-94. PubMed ID: 20583085
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus infection in heart transplant recipients in a hepatitis B endemic area.
Ko WJ; Chou NK; Hsu RB; Chen YS; Wang SS; Chu SH; Lai MY
J Heart Lung Transplant; 2001 Aug; 20(8):865-75. PubMed ID: 11502409
[TBL] [Abstract][Full Text] [Related]
7. Management of chronic viral hepatitis before and after renal transplantation.
Gane E; Pilmore H
Transplantation; 2002 Aug; 74(4):427-37. PubMed ID: 12352899
[TBL] [Abstract][Full Text] [Related]
8. Risk of hepatitis B reactivation in hepatitis B surface antigen seronegative and core antibody seropositive kidney transplant recipients.
Querido S; Weigert A; Adragão T; Rodrigues L; Jorge C; Bruges M; Machado D
Transpl Infect Dis; 2019 Feb; 21(1):e13009. PubMed ID: 30295412
[TBL] [Abstract][Full Text] [Related]
9. Utilization of hepatitis B core antibody positive grafts in living donor liver transplantation.
Udayakumar VP; Surendran S; Padma UD
Indian J Gastroenterol; 2018 Jan; 37(1):39-43. PubMed ID: 29450703
[TBL] [Abstract][Full Text] [Related]
10. Viral hepatitis in solid organ transplantation other than liver.
Vallet-Pichard A; Fontaine H; Mallet V; Pol S
J Hepatol; 2011 Aug; 55(2):474-82. PubMed ID: 21241754
[TBL] [Abstract][Full Text] [Related]
11. Long-term efficacy of hepatitis B vaccination as post-transplant prophylaxis in hepatitis B surface antigen (HBsAg) positive recipients and HBsAg negative recipients of anti-hepatitis B core positive grafts.
Yoshizawa A; Yamashiki N; Ueda Y; Kaido T; Okajima H; Marusawa H; Chiba T; Uemoto S
Hepatol Res; 2016 May; 46(6):541-51. PubMed ID: 26348993
[TBL] [Abstract][Full Text] [Related]
12. Transmission of viral hepatitis by kidney transplantation: donor evaluation and transplant policies (Part 1: hepatitis B virus).
Natov SN; Pereira BJ
Transpl Infect Dis; 2002 Sep; 4(3):117-23. PubMed ID: 12421455
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to hepatitis B surface antigen prevent viral reactivation in recipients of liver grafts from anti-HBC positive donors.
Roque-Afonso AM; Feray C; Samuel D; Simoneau D; Roche B; Emile JF; Gigou M; Shouval D; Dussaix E
Gut; 2002 Jan; 50(1):95-9. PubMed ID: 11772974
[TBL] [Abstract][Full Text] [Related]
14. Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors.
Prakoso E; Strasser SI; Koorey DJ; Verran D; McCaughan GW
Clin Transplant; 2006; 20(3):369-73. PubMed ID: 16824156
[TBL] [Abstract][Full Text] [Related]
15. Management of patients with hepatitis B in special populations.
Cholongitas E; Tziomalos K; Pipili C
World J Gastroenterol; 2015 Feb; 21(6):1738-48. PubMed ID: 25684938
[TBL] [Abstract][Full Text] [Related]
16. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.
Lu SC; Yan LN; Li B; Wen TF; Zhao JC; Cheng NS; Liu C; Liu J; Wang XB; Li XD; Qin S; Zhao LS; Lei BJ; Zhang XH
Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):26-32. PubMed ID: 14969833
[TBL] [Abstract][Full Text] [Related]
17. Liver grafts from anti-hepatitis B core positive donors: a systematic review.
Cholongitas E; Papatheodoridis GV; Burroughs AK
J Hepatol; 2010 Feb; 52(2):272-9. PubMed ID: 20034693
[TBL] [Abstract][Full Text] [Related]
18. [Management of hepatitis B virus and hepatitis C virus infection in chronic kidney failure].
Vallet-Pichard A; Pol S
Nephrol Ther; 2015 Nov; 11(6):507-20. PubMed ID: 26423779
[TBL] [Abstract][Full Text] [Related]
19. Successful withdrawal of antiviral treatment in kidney transplant recipients with chronic hepatitis B viral infection.
Cho JH; Lim JH; Park GY; Kim JS; Kang YJ; Kwon O; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Kim CD
Transpl Infect Dis; 2014 Apr; 16(2):295-303. PubMed ID: 24628837
[TBL] [Abstract][Full Text] [Related]
20. Retrospective evaluation of the risk of hepatitis B virus reactivation after transplantation.
Duhart BT; Honaker MR; Shokouh-Amiri MH; Riely CA; Vera SR; Taylor SL; Al-jedai AH; Gaber AO
Transpl Infect Dis; 2003 Sep; 5(3):126-31. PubMed ID: 14617300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]